Alternatives
Alternatives to Exjade 125 mg tablet for oral suspension
1 other presentations of Deferasirox 125 mg tablet for oral suspension
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Deferasirox), strength (125 mg) and dosage form (tablet for oral suspension) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Exjade 125 mg tablet for oral suspensionThis pageOral | Novartis Pharmaceuticals | US FDA | 30 tablets | Store Exjade tablets at 20°C to 25°C (68°F to 77°F), excursions are permitted between 15°C to 30°C (59°F to 86°F). Protect from moisture. | On request | — | Available on request |
| Deferasirox 125 mg tablet for oral suspensionOral | — | US FDA | 30 tablets, 30 tablets | Store deferasirox tablets for oral suspension at 20°C to 25°C (68°F to 77°F), excursions are permitted to 15°C to 30°C (59°F to 86°F). Protect from moisture. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Exjade 125 mg tablet for oral suspensionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.